Literature DB >> 7824199

Localization of pleiotrophin and midkine in the postnatal developing cerebellum.

K Matsumoto1, A Wanaka, T Mori, A Taguchi, N Ishii, H Muramatsu, T Muramatsu, M Tohyama.   

Abstract

We demonstrated that pleiotrophin (PTN) and midkine (MK), proteins which constitute a novel heparin-binding growth factor family, are expressed in the postnatal developing cerebellar cortex by an immunohistochemical method. The expression patterns of both factors were quite similar both temporally and spatially; the levels of protein expression reached a peak at P7, and strong immunoreactivities were localized primarily in the premigratory zone of the external granular layer, the molecular layer, and the white matter. These findings suggest that PTN and MK are co-localized and thereby exert synergistic functions in the developmental events such as the migration of granule cells and the process outgrowth of neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824199     DOI: 10.1016/0304-3940(94)90762-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  A chondroitin sulfate proteoglycan PTPzeta /RPTPbeta regulates the morphogenesis of Purkinje cell dendrites in the developing cerebellum.

Authors:  Masahiko Tanaka; Nobuaki Maeda; Masaharu Noda; Tohru Marunouchi
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  Novel neuronal effects of midkine on embryonic cerebellar neurons examined using a defined culture system.

Authors:  M Matsuzawa; T Muramatsu; T Yamamori; W Knoll; R Yano
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

3.  Receptor type protein tyrosine phosphatase zeta-pleiotrophin signaling controls endocytic trafficking of DNER that regulates neuritogenesis.

Authors:  Nobuna Fukazawa; Seisuke Yokoyama; Mototsugu Eiraku; Mineko Kengaku; Nobuaki Maeda
Journal:  Mol Cell Biol       Date:  2008-05-12       Impact factor: 4.272

Review 4.  Sugar glues for broken neurons.

Authors:  Vimal P Swarup; Caitlin P Mencio; Vladimir Hlady; Balagurunathan Kuberan
Journal:  Biomol Concepts       Date:  2013-06

Review 5.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 6.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

7.  Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration.

Authors:  N Maeda; M Noda
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

Review 8.  Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury.

Authors:  Emily Ross-Munro; Faith Kwa; Jenny Kreiner; Madhavi Khore; Suzanne L Miller; Mary Tolcos; Bobbi Fleiss; David W Walker
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

9.  Characterizing spatial gene expression heterogeneity in spatially resolved single-cell transcriptomic data with nonuniform cellular densities.

Authors:  Brendan F Miller; Dhananjay Bambah-Mukku; Catherine Dulac; Xiaowei Zhuang; Jean Fan
Journal:  Genome Res       Date:  2021-05-25       Impact factor: 9.043

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.